ПОТРЕБЛЕНИЕ СОЛИ, АРТЕРИАЛЬНАЯ ГИПЕРТЕНЗИЯ И РИСК РАЗВИТИЯ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ. ЧАСТЬ II

Н. Г. Потешкина

Статья

ПОТРЕБЛЕНИЕ СОЛИ, АРТЕРИАЛЬНАЯ ГИПЕРТЕНЗИЯ И РИСК РАЗВИТИЯ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ. ЧАСТЬ II

Н. Г. Потешкина

2011

Статья посвящена проблеме снижения потребления поваренной соли и снижению риска развития сердечно-сосудистых заболеваний. Представлен анализ мировых, рандомизированных, многоцентровых, проспективных клинических исследований, выполненных во второй половине ХХ – начале ХХI веков. Показано, что уменьшение потребления соли приводит к снижению уровней артериального давления как у здоровых, так и у больных артериальной гипертензией, снижению риска сердечно-сосудистых заболеваний, риска как общей, так и кардиальной смертности. Риск возможных неблагоприятных последствий преувеличен и не может быть причиной отказа от стратегического подхода в снижении потребления соли. Представлены научно-обоснованные рекомендованные уровни потребления соли.

Потешкина Н. Г. ПОТРЕБЛЕНИЕ СОЛИ, АРТЕРИАЛЬНАЯ ГИПЕРТЕНЗИЯ И РИСК РАЗВИТИЯ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ. ЧАСТЬ II. Российский кардиологический журнал. 2011;(5):93-102.

Цитирование

Список литературы

1. Lloyd-Jones DM, Hong Y, Labarthe D. et al. AHA Special Report. Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction. The American Heart Association’s Strategic Impact Goal Through 2020 and Beyond. Circulation. 2010; 121: 586–613.

2. Frost CD, Law MR, Wald NJ. By how much does dietary salt reduction lower blood pressure? II-Analysis of observational data within populations. BMJ. 1991; 302: 815–819.

3. Stamler J. The INTERSALT Study: background, methods, findings, and implications. Am J Clin Nutr 1997; 65: 626S-642S.

4. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III: analysis of data from trials of salt reduction. BMJ. 1991; 302: 819–824.

5. Midgley J. P., Matthew A. G.; Greenwood C. M., et al. Effect of Reduced Dietary Sodium on Blood Pressure. A Meta-analysis of Randomized Controlled Trials. JAMA. 1996; 275 (20): 1590–1597.

6. He FJ., MacGregor GA. How Far Should Salt Intake Be Reduced? Hypertension. 2003; 42: 1093–1099.

7. Obarzanek E., Proschan M. A., Vollmer W. M., et al. Individual Blood Pressure Responses to Changes in Salt Intake: Results From the DASH-Sodium Trial. Hypertension, Oct 2003; 42: 459–467.

8. MacGregor GA, Markandu ND, Sagnella GA, et al. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet. 1989; 2: 1244 –1247.

9. Sacks F. M., Svetkey L.R, Vollmer W. M. et al., Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med. 2001; 344: 3–10.

10. Vollmer W. M., Sacks F. M., Ard J., et al. for the DASH-Sodium Collaborative Research Group. Effects of dietary patterns and sodium intake on blood pressure: subgroup results of the DASH-Sodium Trial. Ann Intern Med. 2001; 135: 1019–1028.

11. Cappuccio F. P., Markandu N. D., Carney C. et al. Double-blind randomised trial of modest salt restriction in older people. Lancet. 1997 Sep 20; 350 (9081): 850–854.

12. He F. J.; Markandu N. D.; MacGregor G. A. Modest Salt Reduction Lowers Blood Pressure in Isolated Systolic Hypertension and Combined Hypertension. Hypertension. 2005; 46: 66–70.

13. Pimenta E, Gaddam KK, Oparil S, et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension. 2009; 54: 475–481.

14. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med. 1993; 153: 598–615.

15. Cook N R, Cutler J A, Obarzanek E, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007; 334: 885–893.

16. Cook N R, Obarzanek E, Cutler J A, et al. for the Trials of Hypertension Prevention Collaborative Research Group Joint Effects of Sodium and Potassium Intake on Subsequent Cardiovascular Disease. The Trials of Hypertension Prevention Follow-up Study. Arch Intern Med. 2009; 169 (1): 32–40.

17. Hsing-Yi Chang, Yu-Whuei Hu, Ching-Syang Jack Yue, et al. Effect of potassium-enriched salt on cardiovascular mortality and medical expenses of elderly men. Am J Clin Nutr 2006; 83: 6: 1289–1296.

18. P. Strazzullo, L. D’Elia, N.-B. Kandala, at al. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ, November 24, 2009; 339 (nov24_1): b4567 – b4567.

19. Hooper L., Bartlett C., Smith G. D., et al. Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ 2002; 325: (21 September), 628–632.

20. Alderman M. H., Madhavan S., Cohen H., et al. Low Urinary Sodium Is Associated With Greater Risk of Myocardial Infarction Among Treated Hypertensive Men. Hypertension. 1995; 25: 1144– 1152.

21. Alderman M. H., Cohen H., Madhavan S. Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES I). The Lancet, 1998, 14 March, Volume 351, Issue 9105, Pages 781–785.

22. Alderman M. H., Madhavan S., Ooi W. L. Association of the Renin-Sodium Profile with the Risk of Myocardial Infarction in Patients with Hypertension. N Engl J Med. 1991; 324: 1098–1104.

23. Meade TW, Cooper JA, Peart WS. Plasma renin activity and ischemic heart disease. N Engl J Med. 1993; 329: 616–619.

24. Graudal NA, Gallie M, Garred P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. JAMA. 1998. 279: 1383 –1391.

25. Cutler J. A., Follmann D., Allender P. S. Randomized trials of sodium reduction: an overview. Am J Clin Nutr. 1997; 65, 643S – 651S.

26. Corcoran A. C., Taylor R. D., Page I. H. Controlled Observations on the Effect of Low Sodium Dietotherapy in Essential Hypertension. Circulation 1951; 3: 1–16.

27. World Health Organization. Reducing salt intake in populations: report of a WHO forum and technical meeting, 5–7 October 2006, Paris, France. Geneva, Switzerland: World Health Organization; 2007.

28. Institute of Medicine. Dietary reference intakes for water, potassium, sodium chloride, and sulfate. 1st ed. Washington, DC: The National Academies Press; 2004.

29. Appel L. J., Brands M. W., Daniels S. R., et al. Dietary Approaches to Prevent and Treat Hypertension: A Scientific Statement From the American Heart Association. Hypertension. 2006; 47; 296–308;

30. Ayala C, Kuklina EV, Peralez J. Centers for Disease Control and Prevention (CDC). Application of lower sodium intake recommendations to adults –-United States, 1999–2006. MMWR 2009; 58: 281–283.

31. Lloyd-Jones D, Adams RJ, Brown TM, et al. AHA Statistical Update Heart Disease and Stroke Statistics –2010 Update A Report From the American Heart Association. Circulation 2010; 121: e46-e215.

32. Peralez Gunn J, Kuklina EV, Keenan NL. Centers for Disease Control and Prevention (CDC). Sodium intake among adult – -United States, 2005–2006. MMWR 2010; 58: 746–749.

33. Intersalt Cooperative Research Group: Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ 1988; 297: 319–328.

34. Национальные рекомендации Всероссийского научного общества кардиологов по диагностике и лечению артериальной гипертензии.

Документы

Информация

Автор

Н. Г. Потешкина ГОУ ВПО Российский государственный медицинский университет Федерального агентства по здравоох-ранению и социальному развитию Росздрава, кафедра общей терапии ФУВ, Москва

Название журнала

Российский кардиологический журнал

Ключевые слова

Статья